PARP1 and biliary tract neoplasm: The medical subject headings terms used for the search in ClinicalTrials.gov were (“Recruiting or not yet recruiting” as status), (“biliary tract cancer”, “biliary tract neoplasm”, “cholangiocarcinoma”, “gallbladder cancer”, “Ampulla cancer” as condition/disease) and (“PARP”, “olaparib”, “veliparib”, “niraparib”, “rucaparib”, or “talazoparib” as other terms).